- Home
- Publications
- Publication Search
- Publication Details
Title
TREM2 regulates innate immunity in Alzheimer’s disease
Authors
Keywords
Alzheimer’s disease (AD), Triggering receptor expressed on myeloid cells 2 (TREM2), Innate immunity, Inflammation
Journal
Journal of Neuroinflammation
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-14
DOI
10.1186/s12974-018-1148-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microglia-Mediated Neuroprotection, TREM2 , and Alzheimer’s Disease: Evidence From Optical Imaging
- (2018) Carlo Condello et al. BIOLOGICAL PSYCHIATRY
- Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease
- (2018) M. Casati et al. EUROPEAN JOURNAL OF NEUROLOGY
- TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway
- (2017) Honghua Zheng et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
- (2017) Kevin A. Clayton et al. Frontiers in Neuroscience
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- TREMs in Alzheimer's disease: Genetic and clinical investigations
- (2016) Jia Cheng et al. CLINICA CHIMICA ACTA
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Targeting microglia for the treatment of Alzheimer's Disease
- (2016) Paul D. Wes et al. GLIA
- Dark microglia: A new phenotype predominantly associated with pathological states
- (2016) Kanchan Bisht et al. GLIA
- TREM2 Overexpression has No Improvement on Neuropathology and Cognitive Impairment in Aging APPswe/PS1dE9 Mice
- (2016) Teng Jiang et al. MOLECULAR NEUROBIOLOGY
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- A polarizing question: do M1 and M2 microglia exist?
- (2016) Richard M Ransohoff NATURE NEUROSCIENCE
- Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation
- (2016) Honghua Zheng et al. NEUROBIOLOGY OF AGING
- TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
- (2016) Peng Yuan et al. NEURON
- TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice
- (2016) Teng Jiang et al. NEUROPHARMACOLOGY
- Vps35-dependent recycling of Trem2 regulates microglial function
- (2016) Jie Yin et al. TRAFFIC
- Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
- (2016) Kristi Henjum et al. Alzheimers Research & Therapy
- Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms
- (2016) Daniel L Kober et al. eLife
- Rare TREM2 variants associated with Alzheimer’s disease display reduced cell surface expression
- (2016) Daniel W. Sirkis et al. Acta Neuropathologica Communications
- The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia
- (2015) Panos Roussos et al. Alzheimers & Dementia
- The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease
- (2015) Christina M. Lill et al. Alzheimers & Dementia
- TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
- (2015) Yaming Wang et al. CELL
- Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke
- (2015) M. Kawabori et al. JOURNAL OF NEUROSCIENCE
- Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
- (2015) Yu Tang et al. MOLECULAR NEUROBIOLOGY
- TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
- (2015) Sheng Chih Jin et al. Molecular Neurodegeneration
- Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice
- (2015) Teng Jiang et al. NEUROBIOLOGY OF AGING
- TREM2 variants and risk of Alzheimer’s disease: a meta-analysis
- (2015) Yanjun Lu et al. NEUROLOGICAL SCIENCES
- TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer’s Disease and Schizophrenia
- (2015) Yoko Mori et al. PLoS One
- Evolutionary responses of innate immunity to adaptive immunity
- (2014) Amanda E. Ward et al. INFECTION GENETICS AND EVOLUTION
- Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model
- (2014) Rachel M Bailey et al. Molecular Neurodegeneration
- Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
- (2014) Jason D Ulrich et al. Molecular Neurodegeneration
- Association study ofTREM2polymorphism rs75932628 with late-onset Alzheimer’s disease in Chinese Han population
- (2014) Jianfang Ma et al. NEUROLOGICAL RESEARCH
- Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease
- (2014) Teng Jiang et al. NEUROPSYCHOPHARMACOLOGY
- Evidence of Trem2 Variant Associated with Triple Risk of Alzheimer’s Disease
- (2014) Zainularifeen Abduljaleel et al. PLoS One
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
- (2014) G. Kleinberger et al. Science Translational Medicine
- TREM2 and the neuroimmunology of Alzheimer's disease
- (2013) Suzanne E. Hickman et al. BIOCHEMICAL PHARMACOLOGY
- Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage
- (2013) Patrick Wunderlich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TREM2 in Alzheimer’s disease
- (2013) Teng Jiang et al. MOLECULAR NEUROBIOLOGY
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Variant TREM2 as Risk Factor for Alzheimer's Disease
- (2012) Harald Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1
- (2010) Q. Peng et al. Science Signaling
- TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria
- (2009) Elsa-Noah N'Diaye et al. JOURNAL OF CELL BIOLOGY
- Microglia Mediate the Clearance of Soluble A through Fluid Phase Macropinocytosis
- (2009) S. Mandrekar et al. JOURNAL OF NEUROSCIENCE
- Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation
- (2008) Laura Piccio et al. BRAIN
- Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled A 42 peptide receptor, in microglial cells
- (2008) K. Chen et al. JOURNAL OF LEUKOCYTE BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started